Evidence map›Paper›PMID 19864266›Full record

ReviewJournal of the Royal Society, Interface2010

A review of tissue-engineered skin bioconstructs available for skin reconstruction.

Rostislav V Shevchenko, Stuart L James, S Elizabeth James

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of the Royal Society, Interface, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02089490 (Prospective Follow-up Study for the Evaluation of the Safety and Efficacy of the Dermal Substitute NEVELIA® in the Treatment of Third-degree Burns and Reconstructive Surgery), which is not on this map. Cited by 202 papers.

0numbers the graph read from it
0cells of the map it votes in
202citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02089490 naunknown statusnot on this mapstarted 2014, after this paper: background citation

Prospective Follow-up Study for the Evaluation of the Safety and Efficacy of the Dermal Substitute NEVELIA® in the Treatment of Third-degree Burns and Reconstructive Surgery

TypeinterventionalSponsorSymateseRan2014 to 2016Enrolled30ConditionsThird-degree Burns, Reconstructive SurgeryArmsNEVELIA® implantation
3 · Its place in the literature

Who cites it

202 citing papers in PubMed.

  1. The Effectiveness of PELNACAesthetic plastic surgery · 2025
    Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Skin substitutes: from conventional to 3D bioprinting.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  15. Article
  16. Review
  17. Pig Model to Test Tissue Engineered Skin.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  18. Review
  19. Article
  20. Article

142 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rostislav V ShevchenkoSchool of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK. r.v.shevchenko@brighton.ac.uk
Stuart L James
S Elizabeth James

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Situations where normal autografts cannot be used to replace damaged skin often lead to a greater risk of mortality, prolonged hospital stay and increased expenditure for the National Health Service. There is a substantial need for tissue-engineered skin bioconstructs and research is active in this field. Significant progress has been made over the years in the development and clinical use of bioengineered components of the various skin layers. Off-the-shelf availability of such constructs, or production of sufficient quantities of biological materials to aid rapid wound closure, are often the only means to help patients with major skin loss. The aim of this review is to describe those materials already commercially available for clinical use as well as to give a short insight to those under development. It seeks to provide skin scientists/tissue engineers with the information required to not only develop in vitro models of skin, but to move closer to achieving the ultimate goal of an off-the-shelf, complete full-thickness skin replacement.

Indexed as

Tissue ScaffoldsBiocompatible MaterialsBiomechanical PhenomenaHumansSkin, ArtificialSkin TransplantationTissue EngineeringWound HealingBiocompatible Materials

Identifiers

PMID19864266
PMCPMC2842616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.